Literature DB >> 11555843

Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro.

T Doenst1, G W Goodwin, A M Cedars, M Wang, S Stepkowski, H Taegtmeyer.   

Abstract

It has been observed that opposite changes in cardiac workload result in similar changes in cardiac gene expression. In the current study, the hypothesis that altered gene expression in vivo results in altered substrate fluxes in vitro was tested. Hearts were perfused for 60 minutes with Krebs-Henseleit buffer containing glucose (5 mmol/L) and oleate (0.4 mmol/L). At 30 minutes, either insulin (1 mU/mL) or epinephrine (1 micromol/L) was added. Hearts weighed 35% less after unloading and 25% more after aortic banding. Contractile function in vitro was decreased in transplanted and unchanged in banded hearts. Epinephrine, but not insulin, increased cardiac power. Basal glucose oxidation was initially decreased and then increased by aortic banding. The stimulatory effects of insulin or epinephrine on glucose oxidation were reduced or abolished by unloading, and transiently reduced by banding. Oleate oxidation correlated with cardiac power both before and after stimulation with epinephrine, whereas glucose oxidation correlated only after stimulation. Malonyl-coenzyme A levels did not correlate with rates of fatty acid oxidation. Pyruvate dehydrogenase was not affected by banding or unloading. It was concluded that atrophy and hypertrophy both decrease insulin responsiveness and shift myocardial substrate preference to glucose, consistent with a shift to a fetal pattern of energy consumption; and that the isoform-specific changes that develop in vivo do not change the regulation of key metabolic enzymes when assayed in vitro. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11555843     DOI: 10.1053/meta.2001.25605

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  19 in total

1.  Clinical trials report. Metabolic modulation as a principle for myocardial protection.

Authors:  Heinrich Taegtmeyer; Alexis Woods
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

Review 2.  The metabolic syndrome and the heart--a considered opinion.

Authors:  J G Leichman; V R Lavis; D Aguilar; C R Wilson; H Taegtmeyer
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

3.  Lack of NF-kappaB1 (p105/p50) attenuates unloading-induced downregulation of PPARalpha and PPARalpha-regulated gene expression in rodent heart.

Authors:  Peter Razeghi; Mou-Er Wang; Keith A Youker; Leonard Golfman; Stanislaw Stepkowski; Heinrich Taegtmeyer
Journal:  Cardiovasc Res       Date:  2007-01-03       Impact factor: 10.787

Review 4.  Taking pressure off the heart: the ins and outs of atrophic remodelling.

Authors:  Kedryn K Baskin; Heinrich Taegtmeyer
Journal:  Cardiovasc Res       Date:  2011-02-25       Impact factor: 10.787

5.  Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats.

Authors:  D M Ouwens; C Boer; M Fodor; P de Galan; R J Heine; J A Maassen; M Diamant
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

Review 6.  The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure.

Authors:  Kayla Riggs; Hiba Ali; Heinrich Taegtmeyer; Absalon D Gutierrez
Journal:  Metab Syndr Relat Disord       Date:  2015-06-30       Impact factor: 1.894

7.  MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.

Authors:  Kedryn K Baskin; Meredith R Rodriguez; Seema Kansara; Wenhao Chen; Sylvia Carranza; O Howard Frazier; David J Glass; Heinrich Taegtmeyer
Journal:  J Mol Cell Cardiol       Date:  2014-03-18       Impact factor: 5.000

8.  The Role of Peroxisome Proliferator-Activated Receptor beta/delta on the Inflammatory Basis of Metabolic Disease.

Authors:  Teresa Coll; Emma Barroso; David Alvarez-Guardia; Lucía Serrano; Laia Salvadó; Manuel Merlos; Xavier Palomer; Manuel Vázquez-Carrera
Journal:  PPAR Res       Date:  2010-07-27       Impact factor: 4.964

9.  FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases.

Authors:  Yan G Ni; Na Wang; Dian J Cao; Nita Sachan; David J Morris; Robert D Gerard; Makoto Kuro-O; Beverly A Rothermel; Joseph A Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

10.  Proposed regulation of gene expression by glucose in rodent heart.

Authors:  Martin E Young; Jie Yan; Peter Razeghi; Robert C Cooksey; Patrick H Guthrie; Stanislaw M Stepkowski; Donald A McClain; Rong Tian; Heinrich Taegtmeyer
Journal:  Gene Regul Syst Bio       Date:  2007-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.